Showing results (51-60 of 448) with videos related to
Sort By:
Pageof 45
Patient Related Outcome Measures|December 5, 2014
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPDNicola Scichilone, Alida Benfante, Luca Morandi, et al.NPJ Primary Care Respiratory Medicine|June 17, 2016
Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary diseaseDave Singh, Massimo Corradi, Monica Spinola, et al.Paediatric Respiratory Reviews|July 28, 2004
Mechanisms of rhinovirus-induced asthmaNikolaos G Papadopoulos, Alberto Papi, Stelios Psarras, et al.Lancet (London, England)|December 24, 2017
AsthmaAlberto Papi, Christopher Brightling, Søren E Pedersen, et al.The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.Expert Review of Respiratory Medicine|August 14, 2023
Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthmaTommaso Bigoni, Franco Alfano, Federico Baraldi, et al.Chest|June 6, 2009
Rescue treatment in asthma. More than as-needed bronchodilationAlberto Papi, Gaetano Caramori, Ian M Adcock, et al.Pulmonary Pharmacology & Therapeutics|October 18, 2015
An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthmaSanjeeva Dissanayake, Meena Jain, Birgit Grothe, et al.ERJ Open Research|January 28, 2025
Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?Alvar Agustí, Stefano Aliberti, Francesco Blasi, et al.European Journal of Clinical Investigation|November 10, 2015
Chronic critical illness: the price of survivalAlessandro Marchioni, Riccardo Fantini, Federico Antenora, et al.Pageof 45